Sandro Matosevic
Impact in
- Immunology top 2%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immune cells in cancer
- Immunotherapy and Immune Responses
- Oncology top 5%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Papers in
- Immunology 30
- Immune Cell Function and Interaction 29
- Immune cells in cancer 10
- T-cell and B-cell Immunology 7
- Oncology 14
- CAR-T cell therapy research 12
- Co-authors
- Claudia Zylberberg (8 shared papers)Kyle B. Lupo (12 shared papers)Andrea M. Chambers (7 shared papers)Jiao Wang (12 shared papers)Brian M. Paegel (2 shared papers)Xue Yao (4 shared papers)Frank Baganz (2 shared papers)Shadia I. Jalal (2 shared papers)
- Journals
- Frontiers in Immunology (4 papers)Cytotherapy (2 papers)Cancers (2 papers)Trends in Pharmacological Sciences (2 papers)Advanced Science (2 papers)
- Partner nations
- United StatesUnited KingdomDenmark
In The Last Decade
Sandro Matosevic
47 papers receiving 2.4k citations
Sandro Matosevic's Hit Papers
Peers
Comparison fields: 5 of 120
- Immunology 954
- Oncology 813
- Physiology 128
- Biomaterials 306
- Pharmaceutical Science 140
Countries citing papers authored by Sandro Matosevic
This map shows the geographic impact of Sandro Matosevic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandro Matosevic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandro Matosevic more than expected).
Fields of papers citing papers by Sandro Matosevic
This network shows the impact of papers produced by Sandro Matosevic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandro Matosevic. The network helps show where Sandro Matosevic may publish in the future.
Co-authors
The 25 scholars most cited alongside Sandro Matosevic, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pharmaceutical liposomal drug delivery: a review of new delivery systems and a look at the regulatory landscape Hit paper breakdown → | 2016 | 476 |
| 2 | Immunotherapy in Lung Cancer: Current Landscape and Future Directions Hit paper breakdown → | 2022 | 223 |
| 3 | 2017 | 167 | |
| 4 | 2019 | 149 | |
| 5 | 2013 | 131 | |
| 6 | 2018 | 112 | |
| 7 | 2018 | 103 | |
| 8 | 2018 | 97 | |
| 9 | 2011 | 86 | |
| 10 | 2019 | 80 | |
| 11 | 2020 | 77 | |
| 12 | 2021 | 68 | |
| 13 | 2018 | 68 | |
| 14 | 2021 | 67 | |
| 15 | 2011 | 58 | |
| 16 | 2018 | 45 | |
| 17 | 2019 | 43 | |
| 18 | 2020 | 43 | |
| 19 | 2021 | 41 | |
| 20 | 2017 | 34 |
About Sandro Matosevic
Sandro Matosevic is a scholar working on Immunology, Oncology, Physiology, Molecular Biology and Cancer Research, having authored 48 papers that have together received 2.5k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (29 papers), CAR-T cell therapy research (12 papers), Adenosine and Purinergic Signaling (10 papers), Immune cells in cancer (10 papers), T-cell and B-cell Immunology (7 papers), Lipid Membrane Structure and Behavior (3 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Virus-based gene therapy research (3 papers). The work is most often cited by research in Immunology (954 citations), Oncology (813 citations), Physiology (128 citations), Biomaterials (306 citations) and Pharmaceutical Science (140 citations). Sandro Matosevic has collaborated with scholars based in United States, United Kingdom and Denmark. Frequent co-authors include Claudia Zylberberg, Kyle B. Lupo, Andrea M. Chambers, Jiao Wang, Brian M. Paegel, Xue Yao, Frank Baganz, Shadia I. Jalal, Hirva Mamdani and Ahmed Bilal Khalid. Their work appears in journals such as Frontiers in Immunology, Cytotherapy, Cancers, Trends in Pharmacological Sciences and Advanced Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.